1. 4CPS-191 How well do we cover pharmacogenetic recommendations included in the drugs' summaries of product characteristics (spcs)?. (2nd March 2018) Authors: García-González, X; Ortega, C; Ibañez, S; García, MI; Blanco, C; Salvador, S; Sanjurjo, M; López-Fernández, LA Journal: European journal of hospital pharmacy Issue: Volume 25(2018)Supplement 1 Page Start: A131 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PKP-007 Dpyd snps and disease free survival after capecitabine based adjuvant treatment in colorectal cancer. (25th February 2017) Authors: García-González, X; Pellicer, M; García, MI; García-Alfonso, P; Grávalos, C; Pachón, V; Martinez, V; Martinez-Ortega, P; Sanjurjo, M; López-Fernández, LA Journal: European journal of hospital pharmacy Issue: Volume 24(2017)Supplement 1 Page Start: A196 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PS-020 The cost-effectiveness of screening for dihydropyrimidine dehydrogenase polymorphisms in cancer patients treated with fluoropyrimidines. (24th March 2015) Authors: Cortejoso, L; García, MI; García, X; González-Haba, E; Sanjurjo, M; López-Fernández, L Journal: European journal of hospital pharmacy Issue: Volume 22(2015)Supplement 1 Page Start: A143 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗